Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components

The U.S. Food and Drug Administration released this guidance for blood establishments to assist with donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus.
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.